Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Entrepreneurship
    • Venture Advisory Services
    • Love’s Entrepreneur’s Cup
  • e3
  • Concept Fund
  • iMCI
  • Portfolio
  • Contact

Funding available in Oklahoma for each step of development

    Home News Funding available in Oklahoma for each step of development
    NextPrevious

    Funding available in Oklahoma for each step of development

    By sarah | News | 0 comment | 19 March, 2019 | 0

    By Scott Meacham
    Copyright © 2019, The Oklahoman

    I always tell every new company that I talk to: You have to crawl before you walk and walk before you run. The same thing applies to the capital path.

    The great thing for startups in this state is that The Oklahoma Innovation Model, which is unique in the U.S., has funding available for each of those steps. With the Oklahoma Center for the Advancement of Science & Technology’s (OCAST) as the hub of the Innovation Model, here’s how that continuum of capital works to provide a pipeline to the market.

    For Oklahoma innovators starting in the research and development (R&D) world (which is where many ideas are born) OCAST’s Applied Research and Oklahoma Health Research programs provide early stage R&D awards to stimulate unproven, high-risk concepts and innovation.

    Then at the far end of the capital continuum, the Oklahoma Seed Capital Fund and the Accelerate Oklahoma Fund provide concept, seed and startup equity funds for startups with demonstrated high-growth potential. These deals also attract additional investment from angels and venture capitalists.

    And then there is the in-between — the gap in the capital pipeline between where state R&D funding ends and traditional commercialization funding begins.

    For some companies and researchers who have promising results from R&D but do not yet have the prototype or market validation required to attract traditional equity investment need capital to bridge this gap, it is very difficult (nearly impossible) to find institutional investors or even angels willing to invest until there’s a prototype and some degree of market validation.

    The Technology Business Finance Program (TBFP) has become the way Oklahoma fills that gap.

    “Researchers these days have to cobble together funding from many different sources,” Dan Luton, Director in the OCAST Programs Division, told me. “OCAST is that first funding. To attract other funds, an innovator needs to be able to show the results of that OCAST-funded R&D work. A relatively small TBFP investment to fund a prototype can keep projects moving toward commercialization.”

    TBFP has made 142 awards ($12.22 million) to 126 companies — companies like Selexys Pharmaceuticals, which was acquired by Novartis for up to $665 million, and Novazyme Pharmaceuticals, the source for a ground-breaking FDA-approved treatment for Pompe Disease. TBFP provided Selexys’ initial proof-of-concept funding and was the first investor in Novazyme.

    For the last seven years, TBFP has been self-sustaining. Potential investments are put through a rigorous due diligence process and state review. The success of TBFP companies makes the program successful and that success has provided the return on that funding that has allowed TBFP to be self-sustaining for a number of years, but that money is finally running out.

    The timing is right to reinvest in TBFP. It works! It has been a proven catalyst for jobs and revenue for more than a decade.

    All really big technologies start with baby steps. If it weren’t for TBFP, Oklahoma would be missing a critical step in the capitalization path. Our pipeline of innovation would be disrupted, and we could miss a Selexys or a Novazyme.

    There’s no reason for us to stumble and fall when we’ve proven that we can sprint.

    Scott Meacham is president and CEO of i2E Inc., a nonprofit corporation that mentors many of the state’s technology-based startup companies. i2E receives state appropriations from the Oklahoma Center for the Advancement of Science and Technology. Contact Meacham at i2E_Comments@i2E.org .

    Dan Luton, OCAST, Oklahoma Center for the Advancement of Science and Technology, Scott Meacham, TBFP, Technology Business Finance Program

    Related Post

    • There’s no single path to entrepreneurial success

      By sarah | Comments are Closed

      By Scott Meacham There is no single path to entrepreneurial success. U.S. Patent No. 4,371,752 is just one of the more than thirty-three patents issued to Tulsa born and raised inventor and entrepreneur Gordon MatthewsRead more

    • Nautilus inventor created source of wealth and jobs

      By sarah | Comments are Closed

      By Scott Meacham The inventor of the Nautilus exercise machines created a source of wealth and jobs. Arthur A Jones, the inventor of Nautilus exercise machines, grew up in Seminole, OK. His father practiced medicine.Read more

    • Charles Machine Works a case study in entrepreneurship

      By sarah | Comments are Closed

      By Scott Meacham Charles Machine Works is a case study in entrepreneurship and innovation. To succeed in entrepreneurship, solve a problem that lots of businesses have. You can be even more successful, if the businessRead more

    • A real life success story in Ed Roberts and the Altair 8800

      By sarah | Comments are Closed

      By Scott Meacham Oklahoma State University alumni Ed Roberts is a real life success story with the invention of the Altair 8800 personal computer. About a third of i2E’s clients are in software/IT businesses. WeRead more

    • iMCI leads $750,000 investment in OKC-based PrivacyBrain

      By sarah | Comments are Closed

      Back to Newsletter March 17, 2021 Contact: Sarah Seagraves, Senior VP for Marketing sseagraves@i2E.org OKLAHOMA CITY — i2E Management Co., Inc., (iMCI) recently led a $750,000 seed-round investment in Oklahoma City-based PrivacyBrain. PrivacyBrain is aRead more

    Leave a Comment

    Cancel reply

    You must be logged in to post a comment.

    NextPrevious
    i2E-300dpi-Trans-Light
    • Events
    • News
    • Resources
    • Library
    • Love’s Cup

    Oklahoma City Office

    840 Research Parkway, Suite 250
    OKC, OK 73104
    PHONE 405/235-2305
    Click HERE for printable map with directions.

    Tulsa Office

    618 E. Third Street, Suite 1
    Tulsa, OK 74120
    PHONE 918/582-5592
    Click HERE for printable map with directions.
    Copyright 2021 i2E, Inc. | All Rights Reserved
    • #withOklahomaStartups
    • #withOklahomaStartups
    • #withOklahomaStartups- copy
    • 2016 BrewFest
    • 2018 Paulsen Award Application
    • 2019 Business Plan Submittal Form
    • 2019 Intent to Compete
    • 2019 Oral Competition Submittal Form
    • 2019 Paulsen Award Application
    • 2020 Business Plan Submittal Form
    • 2020 Oral Competition Submittal Form
    • 2020 Paulsen Award Application
    • 2021 Official Application Form
    • 2021 Oral Competition Submittal Form
    • 2021 Paulsen Award Application
    • 4DSales
    • About
    • About i2E
    • About Us
    • ACT Tulsa
    • Add Listing
    • Alkami
    • Biolytx
    • BP Endo
    • Clear River Enviro
    • Concept Fund
    • Contact
    • COVID-19 News from i2E
    • COVID19 Resources for Scalable Startups
    • CreditPoint
    • Datebox
    • DermaMedics
    • DEX Pump
    • DigitalSix
    • Directory
    • Directory Dashboard
    • Docvia
    • Driven Analytics
    • e3
    • e3 Goes Virtual
    • e3: #withOklahomaStartups
    • Entrepreneurial Development
    • Entrepreneurial Summit
    • Entrepreneurial Summit Speakers
    • Entrepreneurs-in-Residence
    • Entrepreneurship
    • Events
    • Events
    • Exaptive
    • Exerbotics
    • Expert TA
    • Founder’s Book Nook
    • Home
    • Home
    • i2E Directory
    • i2E Events
    • iMCI
    • iMCI Investment Funds
    • Investments
    • iRecommend
    • Kirrhos
    • Letter from iMCI’s Executive in Residence in a time of great uncertainty
    • Library
    • Lifetone
    • Linear Health Sciences
    • Love’s Cup
      • Forms
      • High Growth
      • Paulsen Awards
      • Small Business
      • Timeline
    • Love’s Cup is Unstoppable
    • Love’s Cup W-9
    • MaxQ
    • Moleculera Labs
    • Monscierge
    • MS Pen Technologies
    • My Account
    • News
    • Newsletter
    • Newsletter Archive
    • OKBio
    • OKBio Directory
    • OMRF Glioblastoma
    • Otologics Pharmaceuticals
    • Past Winners
    • PhotoniCare
    • PolySkope Labs
    • Portfolio
    • Portfolio 3
    • Private Partners Opportunity Fund
    • Progentec Diagnostics
    • Q&A with Kevin Moore
    • Q&A with Michael Basch
    • Quarterly Report
    • Raw Space for Rent
    • Resources
    • Roll to Roll Technologies
    • Selexys Pharmaceuticals
    • Send a Ride
    • Simergent
    • Spiers New Technologies
    • Synercon Technologies
    • Tailwind
    • Ten Nine Technologies
    • Testimonials
    • Tetherex Pharmaceuticals
    • The Greg Main Distinguished Scholar Award
    • THG Energy Solutions
    • Thoughts from local business leaders and startup founders on the effects of COVID on their industry
    • Thoughts Post Shut In
    • Tulsa Collab: COVID-19 Efforts & Resources for Entrepreneurs
    • Tulsa GEW
    • Valve Systems International
    • Venture Advisory Services
    • Video
    • Virtuoso
    • Webmail Test Page
    • WeGoLook
    • Well Checked Systems
    • Whiteboard CRM
    i2E